Monjazeb, A., Giobbie-Hurder, A., Lako, A., Awad, M., Gentzler, R., Lee, C., … Schoenfeld, J. (2019). A randomized multi-center phase 2 study of combined PD-L1/CTLA-4 inhibition with or without radiation in non-small cell lung cancer patients who progressed on PD-(L)1 directed therapy: ETCTN 10021. In JOURNAL FOR IMMUNOTHERAPY OF CANCER (Vol. 7). BMC.

Monjazeb, Arta, Anita Giobbie-Hurder, Ana Lako, Mark Awad, Ryan Gentzler, Carrie Lee, Joleen Hubbard, et al. “A randomized multi-center phase 2 study of combined PD-L1/CTLA-4 inhibition with or without radiation in non-small cell lung cancer patients who progressed on PD-(L)1 directed therapy: ETCTN 10021.” In JOURNAL FOR IMMUNOTHERAPY OF CANCER, Vol. 7. BMC, 2019.

Monjazeb A, Giobbie-Hurder A, Lako A, Awad M, Gentzler R, Lee C, et al. A randomized multi-center phase 2 study of combined PD-L1/CTLA-4 inhibition with or without radiation in non-small cell lung cancer patients who progressed on PD-(L)1 directed therapy: ETCTN 10021. In: JOURNAL FOR IMMUNOTHERAPY OF CANCER. BMC; 2019.

Monjazeb, Arta, et al. “A randomized multi-center phase 2 study of combined PD-L1/CTLA-4 inhibition with or without radiation in non-small cell lung cancer patients who progressed on PD-(L)1 directed therapy: ETCTN 10021.” JOURNAL FOR IMMUNOTHERAPY OF CANCER, vol. 7, BMC, 2019.

Monjazeb A, Giobbie-Hurder A, Lako A, Awad M, Gentzler R, Lee C, Hubbard J, Abbruzzese J, Jabbour S, Uboha N, Stephans K, Johnson J, Park H, Villaruz L, Kao K, Sharon E, Raben D, Mak R, Streicher H, Chen H, Ahmed M, Rodig S, Hodi FS, Schoenfeld J. A randomized multi-center phase 2 study of combined PD-L1/CTLA-4 inhibition with or without radiation in non-small cell lung cancer patients who progressed on PD-(L)1 directed therapy: ETCTN 10021. JOURNAL FOR IMMUNOTHERAPY OF CANCER. BMC; 2019.